Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-02-18 @ 10:58 AM
Study NCT ID:
NCT02713295
Status:
COMPLETED
Last Update Posted:
2020-04-15
First Post:
2016-03-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-19
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-15
First Submit QC Date:
None
Study First Post Date:
2016-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-14
Last Update Post Date:
2020-04-15
Last Update Post Date Type:
ACTUAL